Hexagon Bio
Developing novel therapeutics by understanding the complex interplay of biological systems.
About
Hexagon Bio is a biotechnology company focused on developing new medicines by leveraging a deep understanding of biological pathways and interactions. They aim to create therapies for diseases with high unmet medical needs.
Key facts
- Website
- hexagonbio.com
- Headquarters
- Menlo Park, United States
- Founded
- 2019
- Employees
- 70
- Total funding
- $100M (Series B)
- Valuation
- Private
- Business model
- B2B
- Tags
- BiotechDrug DiscoveryGenomicsHealthTechTherapeutics
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 21 Sept 2021 | Series B | $75M | Arch Venture Partners |
| 18 Jun 2019 | Seed | $25M | Arch Venture Partners |
Tech stack
Detected on hexagonbio.com, last scanned 23 Sept 2026. Run your own scan
- Frontend
- jQuery
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Email provider
- Google Workspace
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.
Frequently asked
How much funding has Hexagon Bio raised?
Hexagon Bio has raised a total of $100M in funding. The most recent round on record is Series B.
How many employees does Hexagon Bio have?
Hexagon Bio has approximately 70 people on record.